Neko Pharma SPRL
Neko Pharma reported total assets of 725,792 € at the end of the 2025 financial year (annual accounts filed with the NBB on 26 Aug 2026).
The score of Neko Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +28 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Neko Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 27 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 27 Sep 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Neko Pharma's financial analysis
- Solvency57.0%sector median: 51.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Neko Pharma
Neko Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0661.827.337
- VAT number
- BE0661827337
- Peppol
- Registered · 0208:0661827337 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 30 Aug 2016
- Registered office
- 7110 La Louvière
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Public relations and communication activities (NACE 73300)
Neko Pharma (SPRL) has been based in La Louvière since 2016, active in: public relations and communication activities. For 2025, it reports a net profit of 29,665 € and equity of 413,630 €; its revenue is not published. Its solvency stands at 57.0%, above the median of its sector (51.1%).
Companies similar to Neko Pharma
Companies in the same business, of comparable size and area, outside its group.
- Autentica Consulting Public relations and communication activities Uccle · balance sheet 752,133 €
- Nemoco Public relations and communication activities Puurs-Sint-Amands · balance sheet 786,633 €
- Vita Consulting Public relations and communication activities La Hulpe · balance sheet 666,787 €
- I.M.C. Consult Public relations and communication activities Kraainem · balance sheet 666,363 €
- Rigouts & C° Public relations and communication activities Hoogstraten · balance sheet 659,574 €
- Belfort Reizen - Travel Public relations and communication activities Bruges · balance sheet 801,198 €
- Konecto Public relations and communication activities Seraing · balance sheet 656,320 €
- Fun4life Public relations and communication activities Beringen · balance sheet 653,838 €
Frequently asked questions about Neko Pharma
What is the revenue of Neko Pharma?
Neko Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Neko Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0661827337 for Neko Pharma, if the company is VAT-registered. Its company number (CBE) is 0661.827.337.
Where is the registered office of Neko Pharma?
According to the CBE register, the registered office of Neko Pharma is in 7110 La Louvière.
What is the equity of Neko Pharma?
At the close of the 2025 financial year, the equity of Neko Pharma amounts to 413,630 €, a solvency of 57.0% of total assets.
Who manages Neko Pharma?
The register lists 1 active mandates at Neko Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Neko Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →